Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2013) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Assessment of causality of individual adverse events following immunization (AEFI): A WHO tool for global use

(2013) Alberto E. Tozzi et al.   VACCINE

Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours

(2013) M.L. Wumkes et al.   VACCINE

Response to influenza virus vaccination during chemotherapy in patients with breast cancer

(2011) A. Meerveld-Eggink et al.   ANNALS OF ONCOLOGY

Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study

(2011) P Loulergue et al.   BRITISH JOURNAL OF CANCER

Utility of Influenza Vaccination for Oncology Patients

(2010) Daniel A. Pollyea et al.   JOURNAL OF CLINICAL ONCOLOGY